Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Globus Medical (GMED) Convertible Debt (2023)

Globus Medical filings provide 1 years of Convertible Debt readings, the most recent being $417.4 million for Q4 2023.

On a quarterly basis, Convertible Debt changed N/A to $417.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was $417.4 million, a N/A change, with the full-year FY2023 number at $417.4 million, changed N/A from a year prior.
Convertible Debt hit $417.4 million in Q4 2023 for Globus Medical, up from $409.7 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $417.4 million in Q4 2023 to a low of $409.7 million in Q3 2023.